Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-25

Clinical Trial Update: A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effect of roflumilast on airway inflammation and function after allergen challenge in subjects with allergic asthma; the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roflumilast (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: Allergic Asthma | Phase 2 | Status: COMPLETED